15017 Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure

15017 Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure

ABSTRACT IMPACT: Younger patients receiving biologics for rheumatoid arthritis have higher medical expenditure. OBJECTIVES/GOALS: TNF inhibiting biologic disease modifying antirheumatic drugs are among the most highly regarded treatment options for rheumatoid arthritis (RA). We aimed at evaluating t...

Full description

Bibliographic Details
Main Authors:	Robert A. Kelly, Alice C. Ceacareanu, Zachary A.P. Wintrob
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-03-01
Series:	Journal of Clinical and Translational Science
Online Access:	https://www.cambridge.org/core/product/identifier/S2059866121004787/type/journal_article

Similar Items

56600 Statin use and medical expenditure in patients with Parkinson’s disease
by: Anthony J. Lo Piccolo, et al.
Published: (2021-03-01)

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-06-01)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
by: Isaacs, J, et al.
Published: (1992)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
by: Isaacs, J, et al.
Published: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1991)

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
by: Sung Ho Lim, et al.
Published: (2022-07-01)

53034 Melatonin use and occurrence of respiratory illnesses
by: Hannah M. Bowen, et al.
Published: (2021-03-01)

Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
by: Xiao-Kai Chi, et al.
Published: (2023-03-01)

Administration of monoclonal antibodies to b-lymphocytes (rituximab) in rheumatoid arthritis in Russia
by: E L Nasonov, et al.
Published: (2008-08-01)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2004)

67863 Insulin use and depigmentation: a survey of real-world evidence
by: James Lukasik, et al.
Published: (2021-03-01)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2005)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliott, M, et al.
Published: (1993)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliot, M, et al.
Published: (2008)

Missing the benefit of metformin in acute myeloid leukemia: A problem of contrast?
by: Alice C Ceacareanu, et al.
Published: (2017-01-01)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
by: Tanaka T, et al.
Published: (2014-04-01)

NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis
by: Elson, G, et al.
Published: (2011)

EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsin, et al.
Published: (2009-01-01)

EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsin, et al.
Published: (2009-11-01)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
by: Pureun Won, et al.
Published: (2021-06-01)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1989)

HUMAN MONOCLONAL ANTIBODIES TO TNF-? — AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsyn, et al.
Published: (2010-01-01)

HUMAN MONOCLONAL ANTIBODIES TO TNF-? — AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsyn, et al.
Published: (2010-05-01)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1996)

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)
by: E. L. Nasonov, et al.
Published: (2022-11-01)

Application of a pharmacokinetic model of metformin clearance in a population with acute myeloid leukemia
by: Alice C Ceacareanu, et al.
Published: (2018-01-01)

Monoclonal antibodies at the Oncology Institute of Vojvodina: 5-year expenditure
by: Jelić Marija, et al.
Published: (2012-01-01)

Statin type and cancer outcomes in patients with diabetes type 2 and solid tumors
by: Alice C Ceacareanu, et al.
Published: (2021-01-01)

A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis
by: Yang Qin, et al.
Published: (2023-12-01)

QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
by: R.V. Denisova, et al.
Published: (2009-01-01)

QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
by: R.V. Denisova, et al.
Published: (2009-05-01)

Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies [version 1; peer review: 2 approved]
by: Ladislav Senolt
Published: (2019-08-01)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

Antibody therapy for rheumatoid arthritis.
by: Taylor, P
Published: (2003)

Antikeratin antibodies in rheumatoid arthritis
by: J Zabek
Published: (2003-02-01)

Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)